欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号
SE/H/1674/001
药品名称
Eskata
活性成分
hydrogen peroxide 685.0 mg
剂型
Cutaneous solution
上市许可持有人
FGK Representative Service GmbH Germany
参考成员国 - 产品名称
Sweden (SE)
互认成员国 - 产品名称
Germany (DE)
Eskriele 685 mg Lösung zur Anwendung auf der Haut
United Kingdom (Northern Ireland) (XI)
Austria (AT)
France (FR)
Norway (NO)
Eskata
Italy (IT)
Belgium (BE)
Eskata 685 mg solution cutanée
Iceland (IS)
Eskata 40 % húðlausn
Ireland (IE)
Finland (FI)
许可日期
2018/12/05
最近更新日期
2024/05/28
药物ATC编码
D DERMATOLOGICALS
D11AX Other dermatologicals
申请类型
TypeLevel1:
Known Active Substance
TypeLevel2:
Initial Application
TypeLevel3:
Full Dossier Art 8.3(i) Dir 2001/83/EC
TypeLevel4:
Chemical Substance
TypeLevel5:
Prescription Only
附件文件下载
Final PL
|
SE_H_1674_001_Final PL
Date of last change:2024/09/06
Final SPC
|
SE_H_1674_001_Final SPC
Date of last change:2024/09/06
PubAR
|
SE_H_1674_001_PAR
Date of last change:2024/09/06
市场状态
Positive
©2006-2025
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase